🇺🇸 FDA
Company

Enliven

Enliven Therapeutics

ELVN pharma USA

Quick answer

Enliven is a pharma company (ELVN) headquartered in BOULDER, CO, USA with 4 tracked pipeline programs.

Pipeline (4)

project

ELVN-001

Chronic Myeloid Leukemia

Phase 1 · small_molecule · active

1 trials project

ELVN-001

CML (Chronic Myelogenous Leukemia)

Phase 1 · small_molecule · active

1 trials project

ELVN-002

HER2 Mutant Non-small Cell Lung Cancer

Phase 1 · small_molecule · active

1 trials project

ELVN-002

HER2-positive Breast Cancer

Phase 1 · small_molecule · active

1 trials

Patents (5)

patent

US 12240846

5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases

Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11807638

5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases

Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11807649

Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2

Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11767321

5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases

Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10888597

Composition for treating brain stroke

Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)